- Home
- IMKTA vs INVA Comparison
IMKTA vs INVA Comparison
Compare IMKTA & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMKTA
- INVA
- Stock Information
- Founded
- IMKTA 1963
- INVA 1996
- Country
- IMKTA United States
- INVA United States
- Employees
- IMKTA N/A
- INVA N/A
- Industry
- IMKTA Food Chains
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- IMKTA Consumer Staples
- INVA Health Care
- Exchange
- IMKTA Nasdaq
- INVA Nasdaq
- Market Cap
- IMKTA 1.2B
- INVA 1.4B
- IPO Year
- IMKTA N/A
- INVA 2004
- Fundamental
- Price
- IMKTA $62.30
- INVA $21.02
- Analyst Decision
- IMKTA
- INVA Buy
- Analyst Count
- IMKTA 0
- INVA 1
- Target Price
- IMKTA N/A
- INVA $55.00
- AVG Volume (30 Days)
- IMKTA 114.8K
- INVA 1.0M
- Earning Date
- IMKTA 08-07-2025
- INVA 07-30-2025
- Dividend Yield
- IMKTA 1.08%
- INVA N/A
- EPS Growth
- IMKTA N/A
- INVA N/A
- EPS
- IMKTA 3.26
- INVA N/A
- Revenue
- IMKTA $5,410,455,724.00
- INVA $369,844,000.00
- Revenue This Year
- IMKTA N/A
- INVA $3.75
- Revenue Next Year
- IMKTA N/A
- INVA $12.62
- P/E Ratio
- IMKTA $18.75
- INVA N/A
- Revenue Growth
- IMKTA N/A
- INVA 18.70
- 52 Week Low
- IMKTA $58.92
- INVA $15.70
- 52 Week High
- IMKTA $82.01
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- IMKTA 53.17
- INVA 67.87
- Support Level
- IMKTA $59.55
- INVA $21.24
- Resistance Level
- IMKTA $61.94
- INVA $22.00
- Average True Range (ATR)
- IMKTA 1.05
- INVA 0.49
- MACD
- IMKTA 0.11
- INVA -0.02
- Stochastic Oscillator
- IMKTA 83.97
- INVA 71.08
About IMKTA Ingles Markets Incorporated
Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.